GlaxoSmithkline Consumer Healthcare rose 0.74% to Rs 5,581.10 at 14:39 IST on BSE after net profit rose 9.09% to Rs 160.29 crore on 11.15% growth in total income to Rs 1175.46 crore in Q2 September 2014 over Q2 September 2013.
The result was announced during market hours today, 5 November 2014.
Meanwhile, the S&P BSE Sensex was up 67.26 points or 0.24% at 27,927.64.
On BSE, so far 1,066 shares were traded in the counter as against average daily volume of 1,401 shares in the past one quarter.
The stock was volatile. The stock surged as much as 4.63% at the day's high of Rs 5,799 so far during the day, which is a 52-week high for the counter. The stock rose 0.59% at the day's low of Rs 5,573 so far during the day. The stock hit a 52-week low of Rs 4,064.25 on 12 March 2014.
The stock had underperformed the market over the past one month till 3 November 2014, sliding 0.38% compared with Sensex's 4.86% rise. The scrip had, however, outperformed the market in past one quarter, jumping 14.24% as against Sensex's 9.34% rise.
The large-cap company has equity capital of Rs 42.06 crore. Face value per share is Rs 10.
As in the previous accounting period, the company's financial year comprised the period of fifteen months from 1 January 2013 to 31 March 2014, the financial results for period to date for the previous accounting period ended 31 March 2014 are for the nine months ended 30 September 2013, whereas the results of the year to date for current period ended 30 September 2014 represents six months results for the current year and are therefore not comparable.
GlaxoSmithkline Consumer Healthcare (GSK Consumer Healthcare) is a leading player in the malted food drinks segment. Its major brands include Horlicks, Boost, Viva and Maltova.
Powered by Capital Market - Live News
